SI-BONE, Inc (SIBN)

Etorro trading 970x250
SI-BONE, Inc (SIBN) Logo

About SI-BONE, Inc

SI-BONE, Inc., a medical device company, develops implantable devices used in the surgical treatment of the sacropelvic anatomy in the United States and Internationally. The company offers iFuse, a minimally invasive surgical implant system, which is intended to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that causes lower back pain. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California. Address: 471 El Camino Real, Santa Clara, CA, United States, 95050

SI-BONE, Inc News and around…

Latest news about SI-BONE, Inc (SIBN) common stock and company :

Morgan Stanley Says These 3 Stocks Could Surge Over 60% From Current Levels
16 May, 2022 Yahoo! Finance

Investors are facing a confusing environment, with long- and short-term signals sending different messages. Inflation remains stubbornly high, above an 8% annualized rate, and the Federal Reserve has made it clear that additional interest rate hikes are in the offing. Stocks are well off their highs, and despite last Friday's gains, the S&P 500 and the Nasdaq posted their sixth consecutive weekly loss. But there are positives, too. The 1Q22 earnings season gave an upbeat vibe, as more than three

Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
09 May, 2022 Yahoo! Finance

Si-Bone (SIBN) delivered earnings and revenue surprises of -20.93% and 0.31%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

SI-BONE, Inc. Reports First Quarter 2022 Financial Results
09 May, 2022 Yahoo! Finance

SANTA CLARA, Calif., May 09, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter ended March 31, 2022. Recent Highlights Worldwide revenue of $22.4 million for the first quarter 2022, representing a 10% increase over the corresponding period in 2021U.S. revenue of $20.4 million for the first quarter 2022, representing a 9% increase over the corres

Earnings Scheduled For May 9, 2022
09 May, 2022 FinancialContent

Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 ...

SI-BONE's Earnings Outlook
06 May, 2022 FinancialContent

SI-BONE (NASDAQ:SIBN) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know ...

ViewRay (VRAY) Reports Q1 Loss, Tops Revenue Estimates
05 May, 2022 Yahoo! Finance

ViewRay (VRAY) delivered earnings and revenue surprises of 12.50% and 13.55%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Nevro (NVRO) Reports Q1 Loss, Tops Revenue Estimates
04 May, 2022 Yahoo! Finance

Nevro (NVRO) delivered earnings and revenue surprises of 11.71% and 2.02%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Notable Tuesday Option Activity: SIBN, IPI, SITM
03 May, 2022 FinancialContent

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in SI-BONE Inc (SIBN), where a total volume of 1,380 contracts has been traded thus far today, a contract volume which is representative of approximately 138,000 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 62.3% of SIBN's average daily trading volume over the past month, of 221,525 shares..

Earnings Preview: Si-Bone (SIBN) Q1 Earnings Expected to Decline
02 May, 2022 Yahoo! Finance

Si-Bone (SIBN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Wednesday's ETF Movers: IHI, ARKW
20 Apr, 2022 FinancialContent

In trading on Wednesday, the iShares US Medical Devices ETF is outperforming other ETFs, up about 2.6% on the day. Components of that ETF showing particular strength include shares of Si-bone, up about 4.5% and shares of Intuitive Surgical, up about 3.8% on the day.

SI-BONE, Inc. Announces New Technology Add-On Payment for Breakthrough Adult Spinal Deformity Treatment
19 Apr, 2022 Yahoo! Finance

SANTA CLARA, Calif., April 19, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN) a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the Centers for Medicare and Medicaid Services (CMS) has proposed a New Technology Add-on Payment (NTAP) for the iFuse Bedrock Granite™ implant. The Granite implant is intended to provide sacroiliac fusion and sacropelvic fixation as a foundational element for segmental s

SI-BONE To Present at BofA Securities 2022 Healthcare Conference
18 Apr, 2022 Yahoo! Finance

SANTA CLARA, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2022 Bank of America Healthcare Conference in Las Vegas. Management will be hosting a fireside chat presentation on Wednesday, May 11th, 2022, at 12:40 p.m. Pacific Time / 3:40 p.m. Eastern Time. A live webcast of each event, as well as an arc

SI-BONE To Report First Quarter 2022 Financial Results on May 9, 2022
18 Apr, 2022 Yahoo! Finance

SANTA CLARA, Calif., April 18, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the first quarter of 2022 after market close on Monday, May 9, 2022. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the conference call may

Notable Tuesday Option Activity: SIBN, MDB, CWH
12 Apr, 2022 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in SI-BONE Inc (SIBN), where a total of 1,167 contracts have traded so far, representing approximately 116,700 underlying shares. That amounts to about 41.9% of SIBN's average daily trading volume over the past month of 278,755 shares..

Is SI-BONE (NASDAQ:SIBN) A Risky Investment?
04 Apr, 2022 Yahoo! Finance

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Add Up The Pieces: IHI Could Be Worth $70
28 Mar, 2022 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the iShares US.

Chelsea soccer club owner, Roman Abramovich swept up in $19 billion U.K. sanctions hit on Russian oligarchs
10 Mar, 2022 FinancialContent

Chelsea soccer team owner Roman Abramovich will face an asset freeze and travel ban, but the top-ranked club will be allowed to continue football related activities.

‘Rest in peace, dear comrade’ — on Russian TV, analyst toasts to the end of the country’s stock market
03 Mar, 2022 FinancialContent

Russian markets have been closed for four straight days after the country's invasion of Ukraine.

SI-BONE: Q4 Earnings Insights
28 Feb, 2022 FinancialContent

SI-BONE (NASDAQ:SIBN) reported its Q4 earnings results on Monday, February 28, 2022 at 04:00 PM. Here's what investors need to ...

SI-BONE, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Issues 2022 Revenue Guidance
28 Feb, 2022 Yahoo! Finance

SANTA CLARA, Calif., Feb. 28, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the quarter and full year ended December 31, 2021. Recent Highlights Worldwide revenue of $25.2 million for the fourth quarter 2021 and $90.2 million for the full year 2021, representing an increase of 14% and 23%, respectively, over the corresponding periods in 2020U.S. revenue

Earnings Scheduled For February 28, 2022
28 Feb, 2022 FinancialContent

Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its ...

Stocks That Hit 52-Week Lows On Friday
04 Feb, 2022 FinancialContent

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta ...

SI-BONE To Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022
01 Feb, 2022 Yahoo! Finance

SANTA CLARA, Calif., Feb. 01, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced it will report financial results for the fourth quarter and full year 2021 after market close on Monday, February 28, 2022. The company’s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Investors interested in listening to the co

Russian stocks collapse as U.S. orders diplomat families out of Ukraine
24 Jan, 2022 FinancialContent

Russian stocks crashed and the ruble sank to its lowest level in more than a year, as investors feared the triggering of sanctions if the country invades Ukraine.

SI-BONE Announces Revenue for the Fourth Quarter and Full Year 2021
10 Jan, 2022 Yahoo! Finance

Preliminary 2021 revenue of $89.8-90.1 million represents growth of 22%-23%SANTA CLARA, Calif., Jan. 10, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN) (“SI-BONE” or the “Company”), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced its preliminary and unaudited revenue for fourth quarter and full year 2021. Preliminary and unaudited revenue for fourth quarter 2021 is expected to be in the range of $24.9-$25.2 million, refle

Shareholders in SI-BONE (NASDAQ:SIBN) are in the red if they invested a year ago
03 Jan, 2022 Yahoo! Finance

SI-BONE, Inc. ( NASDAQ:SIBN ) shareholders should be happy to see the share price up 18% in the last month. But in...

SI-BONE to participate in 24th Annual Needham Virtual Growth Conference
27 Dec, 2021 Yahoo! Finance

SANTA CLARA, Calif., Dec. 27, 2021 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced management is scheduled to participate in the following investor conference: 24th Annual Needham Virtual Growth Conference on Wednesday, January 12, 2022 at 5:00 p.m. Eastern Time / 2:00 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presen

Usgi Emerging Europe Fund Buys PJSC Lukoil, Rosneft Oil Co, Mining and Metallurgical Company ...
25 Dec, 2021 Yahoo! Finance

Investment company Usgi Emerging Europe Fund (Current Portfolio) buys PJSC Lukoil, Rosneft Oil Co, Mining and Metallurgical Company NORILSK NICKEL PJ, Gazprom Neft PJSC, Novolipetsk Steel PJSC, sells Tatneft PJSC, TCS Group Holding PLC, EVRAZ PLC, Detskymir PJSC, Sistema PJSFC during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Usgi Emerging Europe Fund.

Orbimed Advisors Llc Buys Adagio Therapeutics Inc, Zimmer Biomet Holdings Inc, Biogen Inc, ...
24 Dec, 2021 Yahoo! Finance

New York, NY, based Investment company Orbimed Advisors Llc (Current Portfolio) buys Adagio Therapeutics Inc, Zimmer Biomet Holdings Inc, Biogen Inc, HCA Healthcare Inc, Erasca Inc, sells Prelude Therapeutics Inc, Aurinia Pharmaceuticals Inc, Ascendis Pharma A/S, Natera Inc, Anthem Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, Orbimed Advisors Llc.

MainStay VP Small Cap Growth Portfolio Buys Option Care Health Inc, Leslies Inc, Kratos Defense ...
23 Dec, 2021 Yahoo! Finance

Investment company MainStay VP Small Cap Growth Portfolio (Current Portfolio) buys Option Care Health Inc, Leslies Inc, Kratos Defense & Security Solutions Inc, 908 Devices Inc, SelectQuote Inc, sells Globant SA, Asana Inc, The Hain Celestial Group Inc, SiTime Corp, Vroom Inc during the 3-months ended 2021Q3, according to the most recent filings of the investment company, MainStay VP Small Cap Growth Portfolio.

SI-BONE, Inc (SIBN) is a NASDAQ Common Stock listed in , ,

970x250